Research Groups

Group Beug

Hartmut Beug is a leading expert in the areas of leukaemic renewal and carcinoma progression. He specialises on cell culture models closely mimicking tumourigenesis in vivo.

Group Decker

Thomas Decker was involved in the pioneering studies that led to the identification of Jak-Stat signal transduction. His lab focuses on the interplay between inflammatory and/or microbe-responsive signalling pathways and Jak-Stat signal transduction.

Group Efarl

Robert Eferl is a young investigator focusing on the molecular basis of cancer, bone and lung diseases. He generates transgenic mouse models to define key factors in hepatocellular carcinoma formation and in low bone mass diseases.

Group Kovarik

Robert Eferl is a young investigator focusing on the molecular basis of cancer, bone and lung diseases. He generates transgenic mouse models to define key factors in hepatocellular carcinoma formation and in low bone mass diseases.

Group Mikolitz

Wolfgang Mikulits focuses on tumour progression in liver cancer. His group developed novel, combined in vitro / in vivo cellular models such as immortalised hepatocytes from p19ARF–/– mice, which are fully functional in vivo.

Group Moriggl

Richard Moriggl is a young investigator involved in pioneering work to define cytokine receptor- and Jak-Stat gene functions. His lab focuses on the role of persistently activated Stat3 or Stat5 proteins in leukaemogenesis.

Group Müller

Mathias Müller participated in the pioneering studies that led to the identification of the biological roles of Jaks and Stats by genetic complementation of cytokine signalling defective mutant cell lines. His lab took part in the initial characterisation of Jak2-null mice and subsequently generated Tyk2-deficient mice.

Group Müllner

Ernst W. Müllner focuses on the analysis of primary hematopoietic cell development and maturation, with a particular emphasis on cells of the erythroid lineage. His lab has developed novel cell culture models for chicken, mouse and human erythroblasts.

Group Sexl

Veronika Sexl specialises on the role of Stats, Jaks and connected pathways in mouse leukaemia models. The lab addresses the role of Stat5 in BcrC/Abl-induced leukaemia and the role of MHC-class I antigens and NK/NKT cells in immuno-surveillance of experimental leukaemias induced by the Abelson virus.